ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of...( ADDISON Texas June 23 /- ULURU In...),Health
Navigation Links
ULURU Inc. Announces the Appointment of Ronald A. Ahrens to the Board of Directors
Date:6/23/2008
ADDISON, Texas, June 23 /PRNewswire-FirstCall/ -- ULURU Inc. (Amex: ULU) announced today that Ronald A. Ahrens has been appointed to serve on the Company's Board of Directors.
Mr. Ahrens has been an advisor to Merck & Company, Inc. since 1995, when he retired as President of Merck Consumer Healthcare Group Worldwide. He had previously served as Executive Vice President of Merck Consumer Healthcare Group International. From 1985 to 1990 Mr. Ahrens was Consumer Group President, North America of Bristol-Myers Squibb and previously was President of Bristol Myers Products Division. Prior to 1985, he held senior management and sales and marketing positions with Richardson Vicks, Bristol-Myers Squibb and Procter and Gamble.
"I am extremely impressed with ULURU's range of innovative products and look forward to providing insight and guidance as they commercialize their numerous product opportunities. The company is now at a point where I believe my experience can assist the company to enhance share holder value," said Mr. Ahrens.
Commenting on the appointment, Kerry P. Gray, President and Chief Executive Officer of ULURU, stated, "We are excited to have Ron join our Board, as he has vast experience successfully commercializing numerous products, and has been involved with a wound care company. His extensive industry experience and contacts will be extremely helpful as we commercialize products both internally and with strategic partners."
About ULURU Inc.:
ULURU Inc. is a specialty pharmaceutical company focused on the
development of a portfolio of wound management, plastic surgery and oral
care products to provide patients and consumers improved clinical outcomes
through controlled delivery utilizing its innovative transmucosal delivery
system and Hydrogel Nanoparticle Aggregate technology. For further
information about ULURU Inc., please visit our website at
http://www.uluruinc.com'/>"/>
| SOURCE ULURU Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
2. ULURU Inc. Announces Odd-Lot Buy Back Offer
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
4. ULURU Inc. Reports Third Quarter 2007 Results
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
8. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
9. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
10. ULURU Inc. Reports First Quarter 2008 Financial Results
11. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
Post Your Comments:
(Date:11/27/2009)...RNewswire-USNewswire/ -- Considered a highly risky... ago, solid organ transplantation is now a life-sa...ary men and women who gathered at the Winspear Ope...er from medical centers around the world to celebr...lant Institute (BRTI), one of the pioneers of soli...
(Date:11/27/2009)...ov. 27 Preventing disea...ortunately every year, new vaccines are being adde...ines boost immunity for the same period of time? A...eded to keep immunity strong? ,, In this mont...an Academy of Pediatrics, Michael Pichichero MD, D...
(Date:11/27/2009)...ael, Nov. 27 Shamir Opti... leading provider of innovative products and techn...ay that its board of directors had declared a divi... million (approximately NIS 37.62 million based on...ange), or approximately US$ 0.609 (approximately N...
(Date:11/27/2009)...mission vehicles may reduce future disease burden,...althDay News) -- Encouraging city dwellers to walk...h greater public health benefits than increased us... found. , The study compared the projected heal...port scenarios for London, England, and Delhi, Ind...
(Date:11/27/2009)...ATTLE, Nov. 27 Allrecipes.com , ...anksgiving traffic numbers, with more than 2.8 mil...ng a clear picture of what was served on the bigge...ing meal in 2009 weighed in at 2,225 calories per ...st. According to the Allrecipes site, Sweet Potat...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4[0] Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary[0] Why Some Vaccines May Require A Booster[0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend[0] More Foot Power, Less Car Pollution Best for Health[0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories
...mple University Hospital has,been ranked again as ...disorders by U.S. News & World Report in its 2008 ...ity Hospital - home to the acclaimed Temple Lung C...ter uses a comprehensive and multidisciplinary,app...
...ois hospital in six clinical,areas, CHICAGO, July... clinical specialties -- six of which make it the,... & World Report,s 2008,America,s Best Hospitals is...according to the Top 50 programs,in 16 clinical ar...
...,s 4th Best Hospital Overall, Placing 15 of its 1...10 Clinic Specialties Rated Among Natio...th year in a row,Cleveland Clinic,s cardiac care h... Clinic as one of the nation,s best,hospitals over...
...red the pilot,"Fat Sells" co-created by 25/7 Produ...d writer Gren Wells. Academy Award winner Forest W...xecutive producer along with Broome on,this one-ho...epartment and "Southern Comfort" at Walt Disney St...
...verwhelming, bipartisan,approval to legislation to...-the best outcome possible given the difficult cir... president of the American,College of Physicians (... more than enough to override a,presidential veto,...
...ue,applauds the members of the U.S. House of Repre... Parenthood on Wednesday evening., Calling it a "...Bachmann, Chris Smith, Jim Jordan, Bill Sali, Mike... "I rise today to highlight the practices of an in...
Other Medicine News:Health News:Northwestern Memorial Among America's Best Hospitals in 10 Clinical Specialties According to U.S. News' 2008 Rankings 2Health News:Northwestern Memorial Among America's Best Hospitals in 10 Clinical Specialties According to U.S. News' 2008 Rankings 3Health News:For the 14th Year in a Row, Cleveland Clinic Heart Center Is Ranked No. 1 in U.S. News & World Report 'America's Best Hospitals' Survey 2Health News:For the 14th Year in a Row, Cleveland Clinic Heart Center Is Ranked No. 1 in U.S. News & World Report 'America's Best Hospitals' Survey 3Health News:Whitaker and Broome Get Wells 'Fat' at HBO 2Health News:ACP applauds Senate to vote to pass H.R. 6331 and avert physician payment cut 2Health News:American Life League Applauds Congressional Action Against Planned Parenthood 2Temple University Hospital Ranked Among Best in America for Respiratory Disorders by U.S. News & World ReportNorthwestern Memorial Among America's Best Hospitals in 10 Clinical Specialties According to U.S. News' 2008 RankingsFor the 14th Year in a Row, Cleveland Clinic Heart Center Is Ranked No. 1 in U.S. News & World Report 'America's Best Hospitals' SurveyWhitaker and Broome Get Wells 'Fat' at HBOACP applauds Senate to vote to pass H.R. 6331 and avert physician payment cutAmerican Life League Applauds Congressional Action Against Planned Parenthood
(Date:11/25/2009)...nd, Nov. 25 From November 16-18, ...ring solutions, presented the second edition of th...the special needs of the older population. The con...and audiology from around the world and more than ... with hearing loss for an opportunity to share exp...
(Date:11/25/2009)...RNewswire/ -- The FDA granted traditional approval...ucleoside reverse transcriptase inhibitor (NNRTI)....d for use in treatment-experienced adults who are ...resistant to an NNRTI and other antiretroviral (AR...8-week data from two Phase 3 studies known as DUET...
(Date:11/25/2009)... Remedium Technologies ...am that stops severe bleeding, won first prize and...ory of the Global Security Challenge 2009, company...e than 100 entries from around the world, Remedium...y Summit conference held at the London School of B...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 1The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 2The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 3Census Bureau News Media Advisory 3A Census Bureau to Announce Findings for Income Earnings Poverty and Health Insurance Coverage 56157 1Census Bureau News Media Advisory 3A Census Bureau to Announce Findings for Income Earnings Poverty and Health Insurance Coverage 56157 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 1Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 3...ed with University of Pennsylvania shows promising...aches,are being used to increase milk production o...chers at the University of Pennsylvania School of,...oving drinking water,through a technology created ...the desired results., Penn Vet worked with EAU Te...
...ld at 4:30 p.m. ET today-, SAN CARLOS, Calif., Ma...ced that data from the Phase 2 program in,catheter... of,Non-functional and Occluded catheters with Min...vement in catheter opening at the higher dose and,...esired target product,profile. As a result, Nuvelo...
Other Medicine Technology:Increasing Dairy Milk Production with Electrolyzed Drinking Water 2Increasing Dairy Milk Production with Electrolyzed Drinking Water 3Increasing Dairy Milk Production with Electrolyzed Drinking Water 4Increasing Dairy Milk Production with Electrolyzed Drinking Water 5Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 2Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 3Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |